Extracellular vesicle microRNAs as predictors of response to omalizumab in chronic spontaneous urticaria

Allergy. 2021 Apr;76(4):1274-1277. doi: 10.1111/all.14702. Epub 2020 Dec 31.

Authors

Taha Al-Shaikhly¹, James W MacDonald², Theo K Bammler², Matthew C Altman¹, Andrew G Ayars¹, Daniel H Petroni³, Stephen A Tilles³, William R Henderson¹

Affiliations

¹ Division of Allergy and Infectious Diseases, Department of Medicine, School of Medicine, University of Washington, Seattle, WA, USA.
² Interdisciplinary Center for Exposures, Diseases, Genomics & Environment, Department of Environmental and Occupational Health Sciences, School of Public Health, University of Washington, Seattle, WA, USA.
³ Seattle Allergy and Asthma Research Institute, Seattle, WA, USA.

PMID: 33314187
DOI: 10.1111/all.14702

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Anti-Allergic Agents* / therapeutic use
Chronic Disease
Chronic Urticaria*
Extracellular Vesicles*
Humans
MicroRNAs* / genetics
Omalizumab / therapeutic use
Treatment Outcome
Urticaria* / drug therapy
Urticaria* / genetics

Substances

Anti-Allergic Agents
MicroRNAs
Omalizumab